CSL (CMXHF) PensionAndRetirementBenefit : $208 Mil (As of Dec. 2023)

View and export this data going back to 2009. Start your Free Trial

What is CSL PensionAndRetirementBenefit?

CSL's PensionAndRetirementBenefit for the quarter that ended in Dec. 2023 was $208 Mil.

CSL's quarterly PensionAndRetirementBenefit increased from Dec. 2022 ($202 Mil) to Jun. 2023 ($264 Mil) but then declined from Jun. 2023 ($264 Mil) to Dec. 2023 ($208 Mil).

CSL's annual PensionAndRetirementBenefit declined from Jun. 2021 ($334 Mil) to Jun. 2022 ($189 Mil) but then increased from Jun. 2022 ($189 Mil) to Jun. 2023 ($264 Mil).

CSL PensionAndRetirementBenefit Historical Data

The historical data trend for CSL's PensionAndRetirementBenefit can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CSL PensionAndRetirementBenefit Chart

CSL Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

PensionAndRetirementBenefit

Get a 7-Day Free Trial

342.90

389.20

334.30

189.00

264.00

CSL Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
PensionAndRetirementBenefit	Get a 7-Day Free Trial															291.80	189.00	201.80	264.00	208.00

CSL PensionAndRetirementBenefit Calculation

PensionAndRetirementBenefit is the carrying amount as of the balance sheet date of the portion of the obligations recognized for the various benefits provided to former or inactive employees, their beneficiaries, and covered dependents after employment but before retirement.

CSL (CMXHF) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » CSL Ltd (OTCPK:CMXHF) » Definitions » PensionAndRetirementBenefit

Comparable Companies

Traded in Other Exchanges

CSLLY:USA CSJ:Germany CSL:Australia

Address

655 Elizabeth Street, Melbourne, VIC, AUS, 3000

Website

https://www.csl.com

CSL is one of the largest global biotech companies and has two main segments. CSL Behring either uses plasma-derived proteins or recombinants to treat conditions including immunodeficiencies, bleeding disorders and neurological indications. Seqirus is now the world's second largest influenza vaccination business and was acquired in fiscal 2015. CSL has a strong R&D track record, and the product portfolio and pipeline include non-plasma products as the firm continues to broaden its scope. Originally formed in Australia as a government-owned entity, CSL now earns roughly half its revenue in North America and a quarter in Europe.